Potential Targeted Therapies in Ovarian Cancer.

Yagmur Sisman,Lau Kræsing Vestergaard, Douglas Nogueira Perez de Oliveira,Tim Svenstrup Poulsen,Tine Henrichsen Schnack,Claus Høgdall,Estrid Høgdall

Pharmaceuticals (Basel, Switzerland)（2022）

引用 0|浏览3

暂无评分

摘要

PARP inhibitors are the most frequent potential targeted therapy in HGSC. However, other targeted therapies remain relevant for investigation according to our mutational findings.

查看译文

关键词

DNA sequencing,high-grade serous carcinoma,precision medicine,somatic pathogenic and likely pathogenic mutations,targeted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要